Pannus carateus is a medical term used to describe a specific type of ocular condition characterized by the formation of fibrovascular tissue on the cornea. The word "pannus" refers to an abnormal growth of tissue, specifically in the form of a membrane or layer, while "carateus" denotes the cornea's involvement in the condition.
In pannus carateus, the cornea becomes invaded by a dense layer of blood vessels and connective tissue, leading to vision impairment. This condition typically results from chronic inflammation of the eye, often associated with conditions like allergic conjunctivitis or immune-mediated diseases. The inflammatory response triggers the release of growth factors and induces the formation of new blood vessels and fibrous tissue, leading to the development of pannus carateus.
Symptoms of pannus carateus may include blurred vision, redness, irritation, or a sensation of foreign body in the affected eye. The condition may progress gradually and can be quite debilitating if left untreated.
Treatment for pannus carateus focuses on managing the underlying cause of inflammation and reducing the growth of abnormal blood vessels. Various therapeutic options may be employed, including topical corticosteroids, immunosuppressive medications, or anti-vascular endothelial growth factor (VEGF) agents. In severe cases, surgical intervention might be necessary to excise the fibrous tissue or correct corneal abnormalities. Regular follow-up visits with an ophthalmologist are important to monitor the condition and adjust treatment as needed.
Overall, pannus carateus is a medical term that describes an ocular condition involving the growth of fibrovascular tissue on the cornea, necessitating appropriate management to prevent vision impairment.
